Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
9.16
+0.19 (2.12%)
Nov 21, 2024, 1:10 PM EST - Market open
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $488.92 million as of November 21, 2024. Its market cap has increased by 206.73% in one year.
Market Cap
488.92M
Enterprise Value
449.33M
1-Year Change
206.73%
Ranking
Category
Stock Price
$9.16
Market Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $488.92M, an increase of 254.81%. That is a compound annual growth rate of 14.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 478.80M | 101.85% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emergent BioSolutions | 465.98M |
| UroGen Pharma | 465.88M |
| Monte Rosa Therapeutics | 463.23M |
| Celcuity | 462.63M |
| Treace Medical Concepts | 459.13M |
| Health Catalyst | 458.18M |
| Aura Biosciences | 456.56M |
| Allogene Therapeutics | 450.79M |